She said she had visited the Rancho La Puerta wellness spa in Mexico in August 2022 with two childhood friends after all three turned 50. Navarro described the resulting changes as comprehensive, with two cheerful exceptions.
“It has been a complete lifestyle change, except for the damn rosé and margaritas, which I can’t give up,” she said, adding that the changes had helped her lose roughly four to five pounds each month.
During a later holiday in Greece, Navarro praised a Mediterranean-style diet built around fresh fruit, vegetables, nuts and grilled meat. She also highlighted the relative lack of processed sugar and preservatives, noting that she had not seen a pancake in a month. Greece survived the criticism.
Why are so many The View hosts discussing weight-loss drugs?
Navarro is now one of four current The View panellists who have publicly discussed using medication associated with weight reduction. That makes the daytime programme an unusually concentrated venue for conversations about obesity treatment, prescription drugs and body image.
- Whoopi Goldberg, who marked 20 years on the show during the Season 30 premiere, previously said medication helped after her weight reached “almost 300 pounds” in 2021.
- Joy Behar, a member of the panel since the programme premiered in 1997, said in February that a GLP-1 medication contributed to a 25-pound loss.
- Sunny Hostin previously disclosed using Mounjaro after gaining 40 pounds during the pandemic.
- Ana Navarro has now explicitly connected her own results to Mounjaro, after years of discussing diet, exercise and wellness changes.
Their disclosures reflect how quickly these treatments have entered everyday discussion. They also risk compressing different drugs, medical histories and prescribing reasons into one convenient television label. Daytime broadcasting can cover politics, celebrity interviews and injectable medication before lunch. Efficiency remains undefeated.
What is the difference between Mounjaro and Zepbound?
Mounjaro and Zepbound contain the same active ingredient, tirzepatide, but the US Food and Drug Administration approves the brands for different purposes.
Mounjaro is approved to improve blood-sugar control in adults with type 2 diabetes. Zepbound is the tirzepatide brand approved for chronic weight management in qualifying patients.
Tirzepatide is often grouped into the broader category of GLP-1 medicines, but that description is incomplete. The drug acts on both GIP and GLP-1 receptors, which help regulate blood sugar and appetite. Navarro’s comments did not establish why Mounjaro was prescribed to her, what dose she used or how much of her weight change could be attributed to the medication alone.
The distinction matters because celebrity conversations frequently use drug names as shorthand for weight-loss treatment. The medical details are less tidy than the television version, as medical details tend to be.
How long has Navarro been on The View?
Navarro’s history with the programme also stretches further back than her permanent seat. ABC says she first guest-hosted in 2013, became a contributor in 2015 and began appearing regularly as a guest co-host in November 2018. She joined the panel as a permanent co-host in 2022.
That same year supplied the throwback footage that prompted her Mounjaro remark during the anniversary premiere. Four years later, the clip offered a visible marker of change and an opening for Navarro to disclose the medication publicly.
No further details about her treatment emerged immediately after the September 8 episode. For now, the record consists of one clear acknowledgement, several years of lifestyle commentary and a baby hippo that was wisely unavailable for comment.
